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Abstract
 .We determined the DNA sequence of the adenylosuccinate lyase ASL gene from a 13 year-old female, who showed a
reduced ASL enzymatic activity in lymphocytes and red blood cells and suffered from severe psychomotor retardation. The
patient was the offspring of a non-consanguineous marriage. She was found to be compound heterozygous for two
 .missense-mutations located on different alleles C –G and G –T : the first mutation replaces Pro75 by Ala, the second300 1266
mutation replaces Asp397 by Tyr. q 1998 Elsevier Science B.V.
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1. Introduction
 .Adenylosuccinate lyase ASL; EC 4.3.2.2 cataly-
ses the trans-elimination of fumarate from both
adenylosuccinate and succinylaminoimidazole
 .SAICA ribotide in the pathway of purine biosynthe-
w xsis 1,2 . Diminished ASL levels have been reported
in about 20 patients exhibiting a profile of clinical
features that include autistic behaviour, severe psy-
chomotor retardation and, in some cases, epilepsy
and muscle wasting. The defect is transmitted as an
autosomal recessive trait and leads in body fluids to
an accumulation of two normally undetectable com-
 .pounds, succinyladenosine S-Ado and SAICA ribo-
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side, which are the dephosphorylation products of the
w xtwo substrates of the enzyme 3 .
ASL isoenzymes have not yet been identified.
Nevertheless, the presence of different ASL isoen-
zymes in human tissues was hypothesised by consid-
ering that the inherited defect causes a marked de-
crease of enzyme activity in liver and kidney and a
partial deficiency in lymphocytes, fibroblasts and
muscle, but usually it does not affect erythrocyte and
w xgranulocyte activities 3–5 .
Here we report the results of full-length analysis of
ASL cDNA from a patient displaying, in the contrast
to other cases of ASL deficiency, a significant de-
crease of enzyme activity in both erythrocytes and
w xmixed peripheral blood lymphocytes 6 . The patient
was compound heterozygous for two mutations
 .C –G and G –T . Both parents and healthy300 1266
sister carried only one of the mutations.
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2. Materials and methods
2.1. Patient and control subjects
The patient, a 13 year-old female, was previously
w xdescribed 6,7 . At the time of study, she presented
severe psychomotor retardation and epilepsy. The
concentration of S-Ado and SAICA riboside in the
urine was 0.075 molrmol creatinine and
0.06 molrmol creatinine, respectively. ASL activity
in erythrocytes and mixed peripheral blood lympho-
cytes was reduced to approximately 30% of the nor-
mal value. The erythrocyte enzyme showed normal
substrate affinity, but decreased thermal stability. Fa-
 .  . ther 51 years , mother 48 years and sister 20
.years were asymptomatic, did not excrete detectable
amounts of succinylnucleosides, but elicited abnor-
mal heat denaturation curves of erythrocyte ASL,
showing values between the patient and healthy sub-
w xjects 6 . Normal controls, free of any neurological or
muscular disorders, volunteered for the study. In-
formed consent was obtained in all cases.
2.2. mRNA extraction and first strand cDNA
synthesis
Lymphocytes were purified from heparinized pe-
w xripheral blood 8 . The cells were stimulated at 378C
in 5% CO and RPMI 1640 medium containing2
0.2 mgrml phytohemagglutinin, 10% fetal bovine
serum, 1% penicillin, 3.4 mM L-glutamine, and
w x  .q0.024 mM 2-mercaptoethanol 9 . Poly A RNA
was purified by using a Micro-fast Track kit In-
.vitrogen, San Diego, CA and reverse transcribed
w xaccording to published procedures 10 by using ei-
ther AMV Reverse Transcriptase USB, Cleveland,
. OH and 20-mer antisense primer MWG-Biotech,
.Ebersberg, D located at 1461–1480 bp of the human
liver ASL cDNA sequence reported by Stone et al.
w x y5 or SuperScript RNase H Reverse Transcriptase
 .  . Gibco BRL, NL and oligo dT Pharmacia,12 –18
.Uppsala, S .
2.3. PCR amplification
cDNA generated by AMV Reverse Transcriptase
was amplified with different 20-mer primer pairs
 .Gibco BRL, NL; MWG-Biotech, Ebersberg, D de-
rived from the published sequence of human liver
ASL. These sets of primers allowed the synthesis of
three fragments with the following nucleotide coordi-
w xnates: 25–942, 273–1201, 1073–1480 5 . These PCR
products were subjected to direct sequencing after
asymmetric PCR.
PCR reactions were performed in a 100 ml volume
 .containing 10 mM Tris–HCl pH 9.0 , 50 mM KCl,
1.5 mM MgCl , 320 mM dNTP, 2.5 U Taq poly-2
 .merase Pharmacia, Uppsala, S , 38 pmol of each
primer or 38 pmol of the primer in excess and
7.7 pmol of the limiting primer, in the case of asym-
. metric amplification , and 0.5–1 ml cDNA or PCR
.product . The reaction mixture was heated to 948C
for 5 min, followed by 35 cycles of DNA denatura-
 . tion 30 s at 948C , annealing 60 s at 48–558C, de-
.  .pending on primers and extension 60 s at 728C .
These cycles were followed by a single extension
w xperiod at 728C for 15 min 10 .
PCR products were analysed by electrophoresis on
 .a 1–2% agarose gel depending on band sizes and
w xstained with ethidium bromide 10 .
2.4. Sequencing of PCR products
Asymmetric PCR products were purified with a
 .Geneclean II kit BIO 101, La Jolla, CA and se-
quenced in both directions using appropriate sense
and antisense PCR primers and a Sequenase kit Ver-
.sion 2.0; US Biochemicals, Cleveland, OH accord-
w xing to the manufacturer’s instructions 11 .
2.5. Mutational analysis by restriction enzyme
digestion
cDNA generated by SuperScript RNase Hy Re-
verse Transcriptase was subjected to a full length
amplification using a 20-mer primer pair MWG-Bio-
.tech, Ebersberg, D based on the published sequence
of human liver ASL that allowed the synthesis of a
single fragment with nucleotide coordinates 75–1515.
The PCR product was then symmetrically amplified
in the presence of specific 20-mer primer pairs Gibco
.BRL, NL , generating two different fragments with
nucleotide coordinates 273–462 and 1073–1345. PCR
conditions were as described above with minor modi-
fications.
After precipitation with 0.3 M sodium acetate and
2.5 volume ethanol, the 273–462 and 1073–1345
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 .PCR products 20 ml were digested with 15 U MwoI
 .New England Biolabs; 2 h at 608C and with 15 U
 .Tsp509I New England Biolabs; 2 h at 658C , respec-
tively. The digestion products were separated on a
2% agarose gel and stained with ethidium bromide
w x10 .
3. Results and discussion
To characterise the molecular defect associated
with ASL deficiency, we isolated the cDNA encoding
human liver ASL from cultured lymphoblasts of pa-
tient, both parents and sister, and control subjects.
PCR amplification of control samples resulted in a
Fig. 1. Partial nucleotide sequence of PCR-amplified ASL cDNA
from the patient that has been found compound heterozygous for
a C –G transversion in codon 75 and for a G –T transver-300 1266
sion in codon 397.
Fig. 2. Restriction analysis of ASL cDNA fragments encompass-
ing the C –G and G –T transversions. The fragments with300 1266
 .  .nucleotide coordinates 273–462 left and 1073–1345 right
were amplified, purified, and digested with MwoI and Tsp509I
restriction endonucleases, respectively.
product with the coding sequence identical to the
w xpublished sequence 5 . As shown in Fig. 1, the
patient was compound heterozygous for two muta-
tions not yet described: a C –G transversion corre-300
sponding to a Pro75Ala substitution and a G –T1266
transversion corresponding to an Asp397Tyr substitu-
tion. The mother was heterozygous only for the
second mutation, the father and the healthy sister
only for the first mutation. We did not find a muta-
tion in the codon for Ser413 responsible for the
decreased ASL activity found in the only other pa-
w xtient reported in detail 5 .
The patient and her relatives were confirmed to be
heterozygous for the mutant alleles by demonstrating
the presence of new restriction endonuclease sites
 .generated by the point mutations Fig. 2 . Digestion
of the 273–462 segment by MwoI generated two
fragments of 163 and 27 bp in the wild-type situation
and four fragments of 163, 129, 34, and 27 bp in the
heterozygotes for the C –G transversion, owing to300
the cleavage of the 163 bp fragment carrying the new
restriction site into two smaller products the 34 bp
and 27 bp fragments cannot be separated in the
.agarose gel shown in Fig. 2 . The 1073–1345 seg-
ment was cut by Tsp509I into two fragments of 240
and 33 bp in the wild-type situation, while hetero-
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zygotes for the G –T transversion showed, beside1266
the 240 and 33 bp fragments, two additional products
of 157 and 83 bp resulting from the cleavage of the
240 bp fragment at the new restriction site created by
the point mutation.
The genetic defects identified by using the human
liver ASL sequence provide circumstantial evidence
that the decrease in ASL activity in the patient’s
erythrocytes and lymphocytes could be caused by a
structural lability of the protein. This suggests that
the main ASL activities in erythrocytes and lympho-
cytes are derived from the same gene. It is striking
that the point mutations occur in ASL regions that are
not conserved in prokaryotes, but conserved between
w xhumans and birds 5,12 . At least the Pro397Ala
substitution would significantly alter ASL flexibility,
w xas predicted by secondary structure algorithms 13 .
The case reported here demonstrates the genetic
heterogeneity of ASL defect, which could, at least in
part, account for the marked variability in the clinical
w xexpression of the disease 3,4,6,14 .
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